Medplus Health Services IPO GMP History
Medplus Health Services IPO has been listed on December 23, 2021 at a listing price of ₹1040, against the issue price of ₹796 — a gain of ₹244 (+30.65%). The GMP peaked at ₹320 on 11 December 2021 and reached a low of ₹150 on 22 December 2021. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Medplus Health Services IPO raised ₹1398.29 Cr. through its IPO at a price band of ₹780 to ₹796 per share, with a lot size of 18 shares. The IPO was open for subscription from 13 Dec 2021 to 15 Dec 2021.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 7:27 AM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 22 Dec 2021 | ₹ 150 | — | 19% | — | — |
| 21 Dec 2021 | ₹ 150 | ▼ | 19% | — | — |
| 20 Dec 2021 | ₹ 160 | ▼ | 20% | — | — |
| 18 Dec 2021 | ₹ 200 | ▼ | 25% | — | — |
| 17 Dec 2021 | ₹ 220 | ▲ | 28% | — | — |
| 16 Dec 2021 | ₹ 200 | — | 25% | — | — |
| 15 Dec 2021 | ₹ 200 | ▼ | 25% | — | — |
| 14 Dec 2021 | ₹ 250 | ▼ | 31% | — | — |
| 13 Dec 2021 | ₹ 300 | ▼ | 38% | — | — |
| 11 Dec 2021 | ₹ 320 | ▲ | 40% | — | — |
| 10 Dec 2021 | ₹ 300 | ▲ | 38% | — | — |
| 09 Dec 2021 | ₹ 280 | ▼ | 35% | — | — |
| 08 Dec 2021 | ₹ 300 | — | 38% | — | — |
Medplus Health Services IPO dates
Key dates from opening to listing. Today is 10 November.
- Open 13 Dec 2021
- Close 15 Dec 2021
- Allotment 20 Dec 2021
- Refund/credit 21 Dec 2021
- Listing 23 Dec 2021
Medplus Health Services IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹796 |
|---|---|
| GMP-based estimate (pre-listing) | ₹946 (+18.8%) |
| Listing gain / loss | +₹244 per share |
| Listing date | 23 Dec, 2021 |
| Actual listing price | ₹1040 (+30.65%) |
Is Medplus Health Services IPO GMP reliable?
Grey market premium for Medplus Health Services IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Medplus Health Services IPO full review for a fundamentals-based assessment before making any grey market trades.
Medplus Health Services IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Medplus Health Services IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Medplus Health Services IPO
MedPlus Health Services Limited was founded in 2006 by Gangadi Madhukar Reddy, its Managing Director and CEO. It is the second largest pharmacy retailer in India by revenue for FY2021 and store count, as per the Technopak report.
It sells medicines, vitamins, medical devices and test kits, plus FMCG goods such as toiletries, baby care products, soaps, detergents and sanitisers. It was the first pharmacy retailer in India to offer an omnichannel platform, with store, phone and online orders and click and pick.
It had 2,165 stores across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal and Maharashtra, and follows a cluster-based approach. In fiscal 2021 its share of organised pharmacy retail was 30% in Chennai and Hyderabad and 29% in Bangalore.
The IPO was Rs 1,398.29 crore, with Rs 600.31 crore of fresh issue and Rs 797.98 crore of offer for sale. Rs 467.17 crore was planned for working capital of its subsidiary Optival.
Frequently asked
What is the GMP of Medplus Health Services IPO?
The current Grey Market Premium (GMP) of Medplus Health Services IPO is ₹ 150.
What is the Kostak Price of Medplus Health Services IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Medplus Health Services IPO is not available.
What is the Subject to Sauda Price of Medplus Health Services IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Medplus Health Services IPO?
Medplus Health Services IPO listed on December 23, 2021 at ₹1040, against the issue price of ₹796 — a gain of +30.65%.
How did the GMP of Medplus Health Services IPO trend before listing?
The GMP of Medplus Health Services IPO was stable in its final days before listing. The GMP peaked at ₹320 on 11 December 2021. View the day-wise table above for the complete GMP history.
Explore Medplus Health Services IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
